QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:TCRX

TScan Therapeutics - TCRX Earnings Date, Estimates & Call Transcripts

$1.80
+0.01 (+0.56%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.69
$1.80
50-Day Range
$1.49
$2.26
52-Week Range
$1.45
$5.60
Volume
34,703 shs
Average Volume
315,980 shs
Market Capitalization
$43.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Earnings Summary

Upcoming
Earnings Date
Mar. 8Estimated
Actual EPS
(Nov. 9)
-$0.67 Beat By $0.06
Consensus EPS
(Nov. 9)
-$0.73
Last Year's Q4 EPS
(11/10/2021)
-$0.80
Skip Charts & View Estimated and Actual Earnings Data

TCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TScan Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.71)($0.71)($0.71)
Q2 20231($0.73)($0.73)($0.73)
Q3 20231($0.75)($0.75)($0.75)
Q4 20231($0.77)($0.77)($0.77)
FY 20234($2.96)($2.96)($2.96)

TCRX Earnings Date and Information

TScan Therapeutics last issued its quarterly earnings data on November 9th, 2022. The reported ($0.67) EPS for the quarter, topping analysts' consensus estimates of ($0.73) by $0.06. The company earned $3.36 million during the quarter, compared to the consensus estimate of $3.73 million. TScan Therapeutics has generated $0.00 earnings per share over the last year. Earnings for TScan Therapeutics are expected to decrease in the coming year, from ($2.78) to ($3.05) per share. TScan Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 8th, 2023 based off prior year's report dates.

TScan Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/8/2023
(Estimated)
        
11/9/2022Q3 2022($0.73)($0.67)+$0.06($0.67)$3.73 million$3.36 million
8/10/2022Q2 2022($0.76)($0.63)+$0.13($0.63)$2.66 million$4.06 million
5/9/2022Q1 2022($0.69)($0.67)+$0.02($0.67)$2.21 million$3.02 million
11/10/20219/30/2021($0.61)($0.80)($0.19)($0.80)$2.41 million
8/18/20216/30/2021($0.65)($7.69)($7.04)($7.69)$2.85 million












TScan Therapeutics Earnings - Frequently Asked Questions

When is TScan Therapeutics's earnings date?

TScan Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 8th, 2023 based off last year's report dates. Learn more on TCRX's earnings history.

Did TScan Therapeutics beat their earnings estimates last quarter?

In the previous quarter, TScan Therapeutics (NASDAQ:TCRX) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.73) by $0.06. Learn more on analysts' earnings estimate vs. TCRX's actual earnings.

How much revenue does TScan Therapeutics generate each year?

TScan Therapeutics (NASDAQ:TCRX) has a recorded annual revenue of $13.29 million.

How much profit does TScan Therapeutics generate each year?

TScan Therapeutics (NASDAQ:TCRX) has a recorded net income of -$48.63 million. TCRX has generated $0.00 earnings per share over the last four quarters.

What is TScan Therapeutics's EPS forecast for next year?

TScan Therapeutics's earnings are expected to decrease from ($2.78) per share to ($3.05) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:TCRX) was last updated on 2/7/2023 by MarketBeat.com Staff